Fibromyalgia's Genetic Roots Confirmed: Largest Study Identifies 26 Risk Regions and a Surprising Link to the HTT Gene

For decades, fibromyalgia was dismissed by some as a condition without a clear biological cause — a label that left millions of patients struggling for legitimacy and effective treatment. A landmark study published in Nature Medicine on July 28, 2026, has changed that entirely. By analyzing the genetic data of over 2.5 million adults, including approximately 55,000 fibromyalgia cases, this international research effort provides the strongest evidence yet that fibromyalgia is a neurological disorder with a distinct genetic fingerprint . This article breaks down the key findings: the 26 identified risk regions, the surprising link to the HTT gene, why the condition affects women at a higher rate despite similar genetic risk, and what this means for future treatments.

The Biological Basis: A Disorder of the Nervous System

The study delivers a clear verdict: fibromyalgia is primarily a central nervous system disorder. The researchers found that the heritability of fibromyalgia is exclusively enriched within brain tissues and neural cell types, a finding that points to a biological origin in the brain and spinal cord rather than in muscles, joints, or purely psychological factors . This genetic evidence reframes the condition as a neurological syndrome, not a "diffuse" or unexplained illness .

The 26 Genomic Regions and the Surprising HTT Link

Through a multi-ancestry genome-wide association study (GWAS) meta-analysis, the team identified 26 independent risk loci — specific regions of the genome — that are significantly associated with fibromyalgia .

The most striking finding was that the strongest association was with a coding variant in the HTT gene . The HTT gene is infamous for causing Huntington's disease when mutated, but this new link suggests a shared neurobiological pathway between the two very different conditions. Because drugs targeting HTT are already in clinical trials for Huntington's disease, this discovery opens the door to potentially repurposing those therapies for fibromyalgia .

Beyond HTT, the study pinpointed several other key neural genes. Gene prioritization implicated the HTT regulator GPR52, as well as CAMKV, DCC, DRD2/NCAM1, MDGA2, and CELF4 — all genes with established roles in brain and nerve function . These genes are also linked to physical and psychiatric traits that commonly co-occur with fibromyalgia, providing a genetic explanation for the condition's complex symptom profile .

Genetic Risk Between Sexes: No Major Differences Despite Higher Female Prevalence

One of the most puzzling aspects of fibromyalgia is that about 75% of cases occur in females . The study's analysis of this disparity delivered a surprising result: the genetic architecture of fibromyalgia is largely similar between sexes .

This means that the genes that increase risk for fibromyalgia are essentially the same in men and women . The researchers concluded that the sex difference in prevalence is therefore likely driven by other biological or environmental factors, such as hormones, differences in pain processing, or differential exposure to risk factors . It is worth noting that separate research on multisite chronic pain has identified thousands of sex-specific genetic loci , but these did not appear as strong drivers for fibromyalgia in this particular study.

Genetic Overlap with Other Conditions: Explaining the Comorbidity Puzzle

Fibromyalgia rarely travels alone; patients often suffer from a cluster of other painful and psychiatric conditions. This study provides a genetic explanation for that clinical reality. The analysis revealed strong, positive genetic correlations — with several coefficients above 0.7 — between fibromyalgia and:

• Low back pain
• Post-traumatic stress disorder (PTSD)
• Irritable bowel syndrome (IBS)
• Migraine
• Depression
• Suicidality
• ADHD

These shared genetic mechanisms help explain why these conditions so often cluster together in individuals and families . It suggests that a common underlying genetic vulnerability affecting nervous system function may make a person susceptible to multiple members of this symptom family.

The Role of Environmental Triggers: Genes as a Load, Not a Sentence

The researchers were careful to emphasize that genetics are not destiny. While the study provides the strongest evidence yet for a genetic basis, the authors note that genetics alone do not determine whether someone develops fibromyalgia . Their model is a gene-environment interaction: carrying the identified genetic variants makes a person susceptible, but one or more environmental triggers are usually required to "turn on" the condition .

Reported triggers include:

• Physical trauma (e.g., injury, surgery)
• Infection (including the overlap with long COVID)
• Painful arthritic conditions (e.g., osteoarthritis, rheumatoid arthritis)
• Chronic stress
• Adverse life events

This explains why not everyone with a genetic predisposition develops fibromyalgia, and why the condition often appears after a specific life event. It also points toward preventive strategies for those identified as genetically susceptible.

What This Means for the Future

This study marks a fundamental shift in the scientific understanding of fibromyalgia. The identification of 26 risk loci, the strong HTT link, and the confirmation of a neurological origin provide a biological framework that could finally lead to:

• Better diagnostic tools based on genetic markers
• Biomarker-driven treatment targeting specific neural pathways
• Repurposing existing drugs like those in trials for Huntington's disease
• Personalized risk assessment and preventive strategies that account for environmental triggers

For the estimated 2% of the population affected by fibromyalgia, this research offers something long denied: a clear biological basis for their condition — and with it, a path toward more effective, targeted care .